Ideas to Action:

Independent research for global prosperity

Global Health Policy

CGD experts discuss such issues as health financing, drug resistance, clinical trials, vaccine development, HIV/AIDS, and health-related foreign assistance.

X

Global Health Policy

Feed

 

Global Health in 2012: A Year in Links

The global health legacy of 2012 will be twofold, a year of both increased commitments to health and flat lining budgets. Just look at this past summer: world leaders made a call to end preventable child deaths, the London Summit on Family Planning has resulted in $2.6 billion of commitments, and the International AIDS Conference saw a commitment to the “beginning of the end of AIDS.” While these are all great news, it is still uncertain as to who will pay for these ambitious goals: biggest donors are already scaling down their health aid budgets, and there remains a tremendous resource gap to reach the end of AIDS.

Top 10 Posts of 2012 from CGD’s Global Health Policy Blog

It’s that magical time of the year when we bring you the top 10 most read entries on the CGD Global Health Policy Blog.  Together, these top posts had a total almost 20,000 unique page views. This year the blog asked for your feedback on evaluating the quality of health aid, addressed the debate over entities like the GHI and AMFm, and discussed everything from cash transfers to priority-setting.

The Untapped Potential of Behavioral Design

In the United Kingdom and elsewhere in high-income countries, behavioral economics informed policies are all the rage. The argument justifying behavioral approaches is well-known: traditional economics assumes that humans are rational and will make decisions that maximize their well-being, whereas in fact, many people still make decisions with harmful, self-defeating consequences.

A Warm Welcome to John May

This week we are pleased to announce a new arrival to the CGD global health policy team, John May. John joins us from his previous position as Lead Population Specialist at the World Bank and will be working on issues relating to population and development as a visiting fellow at CGD. John has 35 years of international experience in population, reproductive health, and HIV/AIDS issues.

Pakistan’s Politicians Play Deadly Games with Patients’ Lives

There are new reports of casualties in Pakistan but not from terrorism. Instead, some 150 poor patients died after receiving contaminated drugs from a public cardiology pharmacy in Lahore because the country’s politicians abolished the federal health ministry without creating an appropriate national drug regulatory agency, as explained in a recent Lancet article by Dr. Sania Nishtar. The failure was not only predictable but predicted.

Welcome Victoria Fan to CGD

Today we are excited to welcome Victoria Fan to CGD as a global health research fellow. Victoria is a health economist with extensive experience in the analysis and evaluation of health insurance, health financing,  and other public health policies, mainly in India as well as China and the U.S. (State of Vermont).

AMCs: The Journey from Idea to Action

This is a joint post with Kate McQueston

November 12th is fast approaching and with it comes world pneumonia day. Unfortunately, pneumococcal diseases still pose an enormous global threat--remaining the leading cause of death for children worldwide and taking the lives of 1.4 million children under five years annually. What’s more—a staggering 98% of these children live in developing countries.

Not Too Late to Ride the Hype: USAID and NCDs

This is a joint post with Amanda Glassman.

Everyone seems to be throwing their hat into the ring in the battle against non-communicable disease (NCD), from George W. Bush to Lance Armstrong. Now it appears USAID has entered the mix as well. Despite the agency’s absence from a CGD sponsored panel discussion last week, the USAID communications department is shifting into full gear—implying that they plan to join the fight after all.

Pages